Thursday, January 13, 2022

Federal Govt Wants Racial Qualifications Added to COVID-19 Treatments; FDA Wants Race, Ethnicity Factored in Administering COVID Drugs; Biden Admin Quietly Creates Creepy Database Storing Info About Unvaxxed People Who Request Religious Exemptions, and other C-Virus related stories

Photo: Eve Edelheit/The WA Post/Getty Images
Federal Government Wants Racial Qualifications Added to COVID-19 Treatments:
Are you ready for woke death panels?
The federal government currently controls the market of monoclonal antibodies that are used to treat cases of the coronavirus and regulates the supply allocated to the states. Monoclonal antibodies are effective treatments and in some cases are literal lifesavers.
Some state leaders, like Florida Gov. Ron DeSantis, have requested that the federal government release its control of the market, which in many places has been unable to keep up with demand.
So far, President Joe Biden’s administration hasn’t budged. And what do we get for the federal government’s role in this treatment’s distribution?
Racialized eligibility requirements.
The New York City Department of Health and Mental Hygiene made news when it issued guidance on its website at the beginning of the year that it would consider race when determining who would be given the potentially lifesaving COVID-19 treatments. --->READ MORE HERE
FDA wants race, ethnicity factored in administering COVID drugs:
The Food and Drug Administration is urging health care providers to consider race or ethnicity as well as underlying medical conditions when classifying individuals as “high risk for progression to severe COVID-19″ and qualifying for antibody treatment.
A fact sheet issued by the agency detailing the emergency use authorization of the drug sotrovimab for treatment of mild to moderate COVID-19 cases includes a list of medical conditions that may qualify patients for the treatment.
Those conditions include advanced age (65 or older), obesity, pregnancy, diabetes, cardiovascular disease, chronic lung disease, and neurodevelopmental disorders.
The document, which was last updated in December, also notes that “[o]ther medical conditions or factors (for example, race or ethnicity) may also place individual patients at high risk for progression to severe COVID-19.”
As the treatment is specified as being for mild to moderate cases, it is not authorized for patients who are hospitalized because of COVID-19, require oxygen therapy due to the virus, or require an increase in oxygen flow --->READ MORE HERE
Follow links below to related stories and resources:

+++++Biden Admin Quietly Creates Creepy Database Storing Information About Unvaxxed People Who Request Religious Exemptions+++++

COVID loses 50% of ability to infect after 10 seconds in office air: study

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.

No comments: